The activation-induced cytidine deaminase (AID) is required for somatic hypermutation (SHM) and class-switch recombination (CSR) of immunoglobulin (Ig) genes, both of which are associated with DNA double-strand breaks (DSBs). As AID is capable of deaminating deoxy-cytidine (dC) to deoxy-uracil (dU), it might induce nicks (single strand DNA breaks) and also DNA DSBs via a U-DNA glycosylase-mediated base excision repair pathway (‘DNA-substrate model’). Alternatively, AID functions like its closest homologue Apobec1 as a catalytic subunit of a RNA editing holoenzyme (‘RNA-substrate model’). Although rearranged Vλ genes are preferred targets of SHM we found that germinal center (GC) B cells of AID-proficient and -deficient Vλ1-expressing GC B cells display a similar frequency, distribution, and sequence preference of DSBs in rearranged and also in germline Vλ1 genes. The possible roles of DSBs in relation to AID function and SHM are discussed.
Skip Nav Destination
Article navigation
6 May 2002
Brief Definitive Report|
May 06 2002
DNA Double-Strand Breaks : Prior to but not Sufficient in Targeting Hypermutation
Linda Bross,
Linda Bross
1Basel Institute for Immunology, CH-4005 Basel, Switzerland
3Department of Immunology, Research Institute Growth and Development, University of Maastricht, NL-6200 MD Maastricht, Netherlands
Search for other works by this author on:
Masamichi Muramatsu,
Masamichi Muramatsu
2Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan
Search for other works by this author on:
Kazuo Kinoshita,
Kazuo Kinoshita
2Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan
Search for other works by this author on:
Tasuku Honjo,
Tasuku Honjo
2Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan
Search for other works by this author on:
Heinz Jacobs
Heinz Jacobs
1Basel Institute for Immunology, CH-4005 Basel, Switzerland
3Department of Immunology, Research Institute Growth and Development, University of Maastricht, NL-6200 MD Maastricht, Netherlands
Search for other works by this author on:
Linda Bross
1Basel Institute for Immunology, CH-4005 Basel, Switzerland
3Department of Immunology, Research Institute Growth and Development, University of Maastricht, NL-6200 MD Maastricht, Netherlands
Masamichi Muramatsu
2Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan
Kazuo Kinoshita
2Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan
Tasuku Honjo
2Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan
Heinz Jacobs
1Basel Institute for Immunology, CH-4005 Basel, Switzerland
3Department of Immunology, Research Institute Growth and Development, University of Maastricht, NL-6200 MD Maastricht, Netherlands
Address correspondence to Heinz Jacobs, University of Maastricht, Research Institute Growth & Development, Dept. of Immunology, Universiteits Singel 50, 6200 MD Maastricht, The Netherlands. Phone: 31-43-388-2114; Fax: 31-43-388-4164; E-mail: [email protected]
The online version of this article contains supplemental material.
Received:
October 16 2001
Revision Received:
January 18 2002
Accepted:
January 24 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2002
J Exp Med (2002) 195 (9): 1187–1192.
Article history
Received:
October 16 2001
Revision Received:
January 18 2002
Accepted:
January 24 2002
Citation
Linda Bross, Masamichi Muramatsu, Kazuo Kinoshita, Tasuku Honjo, Heinz Jacobs; DNA Double-Strand Breaks : Prior to but not Sufficient in Targeting Hypermutation . J Exp Med 6 May 2002; 195 (9): 1187–1192. doi: https://doi.org/10.1084/jem.20011749
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement